SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021966
Filing Date
2022-11-03
Accepted
2022-11-03 17:00:58
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20220930.htm   iXBRL 10-Q 2197272
2 EX-31.1 cycn-ex31_1.htm EX-31.1 15385
3 EX-31.2 cycn-ex31_2.htm EX-31.2 15393
4 EX-32.1 cycn-ex32_1.htm EX-32.1 8841
5 EX-32.2 cycn-ex32_2.htm EX-32.2 8851
  Complete submission text file 0000950170-22-021966.txt   6948052

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20220930_pre.xml EX-101.PRE 287570
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20220930_lab.xml EX-101.LAB 405769
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycn-20220930_cal.xml EX-101.CAL 31878
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20220930.xsd EX-101.SCH 50240
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycn-20220930_def.xml EX-101.DEF 180471
54 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20220930_htm.xml XML 1138359
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 221358932
SIC: 2834 Pharmaceutical Preparations